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To address the question of whether users of herbal products (HPs) are exposed to harmful28
contaminants, we evaluated six HPs mostly patronized in Kumasi for heavy metal29
contamination and assessed the health risk associated with their use. This study is one of the30
first safety evaluation studies on finished multiherbal products in the region.31
Method32
Three antimalarial, two antidiabetic and one antihypertensive HPs were selected after a mini-survey33
and coded randomly as HP A-F.  The HPs were acid digested for quantitative analysis of heavy metals34
using Inductively Coupled Plasma Mass Spectrometer. Hg quantification was carried out using cold35
vapour atomic absorption spectroscopy.36
Results37
The cancer risk estimation values for the carcinogenic metals ranged between 1.54x10-9 to 3.73x10-438
and were all within acceptable limits. The non-cancer health risk evaluation revealed that, some of39
the products pose health risk to consumers. The estimated daily intake (EDI) for As in HPF was40
2.48x10-4 mg/kg/day compared to the reference limit of 1.67x10-4 mg/kg/day. HPF also had high41
hazard index (HI) of 5.70 (HI >1) in children as compared to 1.68 (HI >1) in adults showing a 3.442
folds increase in the health risk among the former.43
Conclusion44
The six polyherbal products exhibited carcinogenic risk within acceptable limits. Although, the non-45
carcinogenic risk assessment of products HPA to HPE suggests safety, this can only be ascertained46
3
after further characterization of their health risks in detailed chronic toxicity studies. The high HI for47
product HPF suggests health risk for consumers of this product.48
49
Keywords: Cancer risk, estimated daily intake, exposure, hazard index, hazard quotient, heavy50
metals, herbal medicinal products, risk assessment.51
52
1.0 Introduction53
The use of Herbal Medicines (HM) for healthcare delivery dates back in centuries, and it is likely one54
of the oldest methods of healthcare delivery in many parts of the world, [1]. HMs are used for55
preventive, curative and chronic disease management. HM forms the fabric of the healthcare systems56
in many low income and middle-income countries and has had an enormous contribution to the health57
care system in Ghana. In recent years, the production and patronage of herbal medicinal products58
(HMPs) in Ghana for therapeutic purposes have increased substantially, [2]. The WHO estimated that59
close to 80% of the developing world’s population rely on herbal medicine for their basic healthcare60
needs, [3]. In the light of modern tools and technologies, HMs in Ghana have seen substantial61
improvement in dosage form formulations, packaging and reported efficacies, [4]. Medicinal value62
of these herbal preparations is usually due to the presence of essential phytochemicals such as tannins,63
alkaloids, flavonoids and phenolic compounds that serve as active compounds in these medicinal64
products, [5]. The phytochemicals are secondary plant metabolites produced and or stored for a65
variety of reasons including defence and protection against pest and diseases. In addition to the66
presence of active principle or compound(s), the herbal mixture may contain foreign toxic substances67
including pesticides and heavy metal residues which may cause a health risk to human systems and68
animals, [6].69
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Elevated heavy metal levels in medicinal plants have been associated with plants exposed to heavy70
metal polluted waters, the use of pesticides and other agrochemicals, plants growing along heavy71
traffic ways, previous dump-sites and near mining arrears, [7, 8]. When the herbal medicinal plants72
are processed into herbal preparations and consumed by humans, the heavy metal contaminants enter73
into the human system and cause health problems, [5]. It is believed that herbal medicine is one of74
the commonest modes of human exposure to heavy metals. Heavy metal intake through herbal75
products should, therefore, be regulated to avoid excessive build-ups in humans, [5, 6]. Though76
Ghana's Food and Drugs Authority (FDA) has been charged with controlling commodities for human77
use including herbal products and the organization is doing its best. Many HPs still enters the market78
without FDA registration and or without pre-market and post-market safety data. The FDA is also79
unable to carry out regular post-market surveillance of HPs on the market probably due to resource80
strength compared to the huge HPs on the market resulting in data gap. There is, therefore, a call for81
regular monitoring and surveillance studies to protect the health of the general public.82
83
The increased use of agrochemical such as pesticides in Ghana to fight pest has increased the risk of84
heavy metal contamination these days and poses a health risk. The surge in the use of mercury and85
arsenic for small-scale illegal gold mining operations popularly known as ‘galamsey’ in the country86
in recent years is a major health concern both to policymakers and public health professionals. The87
heavy metals may finally end up in the tissues of these higher medicinal plants and into humans88
through the herbal preparations. Recently, waters near the Obuasi and Takwa gold mines in Ghana89
were found to be contaminated with heavy metals, [7, 9]. Some foodstuffs [10] and tea products [11]90
were also found to be contaminated with heavy metals and unsafe for consumption.  Mutations in the91
genetic material, cancer, central nervous system disorders, liver and kidney toxicities are among the92
reported health problems associated with heavy metals [5]. As, Cd, Pb and Hg are among the most93
toxic metal contaminants based on previous reports, [12, 13]. Lead poisoning causes abdominal pain,94
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severe anaemia and haemoglobulinuria [5] and arsenic poisoning may cause skin lesions, cancer95
[12], diabetes and lung disease [14, 15]. Mercury poisoning has been associated with cardiovascular96
problems, neuropathy, tremors, nephrotoxicity, immunotoxicity, carcinogenicity and death, [13,97
16]. Cadmium, on the other hand, has been associated with increased risk of hormone-dependent98
cancers including endometrial cancer [17], nephrotoxicity, skeletal damage and cardiovascular health99
problems, [18].100
101
Due to methodological challenges and the complex nature of multi-herbal mixtures, researchers shy102
away from it until recently resulting in a paucity of data concerning multi-herbal preparations on the103
market. There is also the lack of pre-market and post-market safety and quality control data on most104
certified and uncertified herbal medicinal products on the Ghanaian market, [19]. The present study,105
therefore, determined the presence of heavy metal contaminants in six commonly used herbal106
medicinal products in Kumasi metropolis of Ghana and evaluated the health and cancer risks107





A mini survey was carried out among some randomly selected herbal medicine users and pharmacy113
shops that also sell herbal medicine on wholesale or in retail. The mini survey was carried out in114
Kejatia, Bantama and Ash-town districts in the Kumasi Metropolis. Herbal medicine users were asked115
about the anti-malarial, anti-hypertensive and anti-diabetic herbal medicinal products they go for116
when unwell. Also, the wholesale and retail pharmacy shops involved in the study were asked about117
the most patronized antimalarial, anti-diabetic and anti-hypertensive HMPs in their collections.118
Participation in the interview was entirely voluntarily, interviewees were free to opt out of the study119
6
at any time, no minors were involved in this study and the minimum age of the participants was over120
20 years. To partake in this mini-interview, the herbal medicine user needed to be at least 18 years121
and over and gave their consent and wiliness to part take in the study. Participants were asked not to122
give any identification numbers or their family names during the short interview. The list was123
compiled and tallied. The top 3 antimalarial (fig. 4A), top 2 anti-diabetics (fig. 4B) and the top 1 anti-124
hypertensive (fig. 4C) were selected for the heavy metal study. The six HMPs were randomly coded125
for ethical reasons and henceforth shall be represented by their random codes; HPA, HPB…HPF.126
127
2.2 Wet di-acid digestion of the herbal products (HPs)128
For the herbal preparations wet di-acid digestion comprising of nitric acid (HNO3) and perchloric129
acid (HClO4) digestion method was employed, [20 - 22]. Measurements were made in triplicate and130
the averages were reported.131
132
2.3 Agilent ICP-MS 7700 series heavy metal and elemental analysis133
Heavy metals and trace elements present in the digested herbal samples were analyzed using134
Inductively Coupled Plasma-Mass Spectrometer (ICP-MS); Agilent ICP-MS 7700x (Agilent135
Technologies, Inc. Hachioji-shi, Tokyo, Japan). Analytical grade calibration standards solution and136
blank were run prior to sample injection. All solutions used were of analytical grade. The ICP-MS137
7700x has high detection power, [23-24] and the obtained results were in parts per billion (ppb) and138
the final results were obtained by calculating back into the undiluted solution. The Pb, As, Cd, Cr,139
Cu, Ni, and Mn content in the HMPs were determined using this ICP-MS instrument and standard140
method for metal analysis with this instrument was followed.141
142
Instrument conditions and quality control143
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The instrument was rinsed with water and recalibrated after every ten runs. Linear analytical range144
(LAR) standards of known concentrations (cal zero, 25 ppb, 50 ppb and 100 ppb) of each metal were145
used as external standards. The analysis was first carried out in no gas mode (without the introduction146
of He gas). It was repeated in a gas mode (He gas was introduced) due to the polyvalent metals like147
Cr. The detector was set at analogue mode during the no gas mode analysis, but the detector was set148
at pulse during the gas mode analysis. The recovery for the standards of Cr, Pb, As, Cd, Mn, Cu and149
Ni were between 91% and 108%. The relative standard deviations between replicate analyses were150
all less than 6%. Continue calibration verification standard (CCV) of 25 ppb was run after every 10151
samples and at the end of every sequence. The measured CCV values ranged from 23.0 ppb to 27.31152
ppb (within ± 10%). The quality control parameters of all steps of validation proved the accuracy of153
the results, [23-25]. The limit of detection (LOD) for Cr, As, Cd, Mn, Pb, Cu and Ni was 0.004 ppm.154
155
2.4 Mercury analysis with cold vapour atomic adsorption spectrometer (CV-AAS)156
Mercury analysis and quantification was carried out on cold vapour atomic adsorption spectrometer157
Varian SpectrAA.240FS (Varian Inc, California, USA) equipped with cold vapour generation158
accessory (VGA-77) using the cold vapour technique. Mercury in the digested sample was reduced159
to elemental mercury using SnCl2 solution as reductant and deionized water as an acid to cold vapour160
VGA system. Freshly prepared Hg standard solution (1 mL/L) was made by appropriate dilution and161
used for prepared working standard solution, [26-27]. Standard samples and blanks were analysed162
following the same procedure. The system plots calibration curve for the standards which it uses to163
determine the Hg content in the diluted sample. The final concentrations were obtained by calculating164
back the Hg concentrations in the original samples.165
166
167
Instrument conditions and quality control for Hg168
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The Varian SpectrAA.240FS cold vapour atomic absorption spectrometer equipped with autosampler169
was set at automix sampling mode for mercury analysis. Measurements were done as described before170
[26-28].  The peak height measurement mode was used for the analysis. Measurements were carried171
out in triplicate. Smoothing was set at 10 points and reading was done at 253.7 nm with a slit width172
of 0.5R nm and a lamp current of 4.0 mA. Gain for the analysis was at 83%. Standards of 10 µg/L,173
20 µg/L and 50 µg/L were used. Re-slope rate was 500 with 2 re-slope standards. Re-slope lower174
limit was 85% and the upper limit was 115%. Calibration algorithm was set to linear with a lower175
calibration limit of 75% and an upper calibration limit of 150%. Measurement time was 5.0 seconds176
with a pre-read delay of 45 seconds. The relative standard deviation between replicate analyses ranged177
from 2.3% to 4.4 %. The ‘r’ value was 0.9998. The linear absorption equation for the estimation of178
analyte concentration (C) was179
Abs = 0.01731*C + 0.01271 …………………………………………… (1)180
Where Abs is the sample absorption at 253.7 nm wavelength.181
182
2.5 Health risk assessments183
2.5.1 Estimated Daily Intake of the heavy metals184
The estimated daily intake (EDI) of each heavy metal (Cr, Mn, Ni, Cu, As, Cd, Pb and Hg) present185
in the mixture was determined by the following equation [29, 30];186
= ×  …………………………..………………………………… (2)187
Where; EDI is the estimated daily intake of the heavy metal, C is the determined heavy metal188
content in the HP, ED is the daily dosage of the HP and WAB is the Ghanaian average body weight;189
(65 kg adults, 24 kg children), [30-31]. International oral reference dose values for the heavy metals190
RfDo (mg kg-1 day-1) used in this study were; 0.02 for Cr (VI); 0.14 for Mn; 0.02 for Ni; 0.001 for191
Cu; 0.003 for As; 0.001 for Cd; 0.004 for Pb and 0.0001for Hg. The reference values as stated by192
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FAO/WHO (Codex Alimentarious Commission) [32], US EPA 2015 [33] and other published193
materials [27- 30, 34].194
195
2.5.2 Target hazard quotient for non-carcinogenic risk196
The equation below was used to estimate the targeted hazard quotient (THQ) of the non-197
carcinogenic effects of the heavy metals present in the herbal products.198




EFr (exposure frequency): Malaria incidence density of approximately 5 infections per person per201
year was considered for sub-Saharan African and for this study [35]. Anti-malarials: 5 malaria202
incidences a year and dosages as written on the product label were used. Anti-diabetic or hypertensive203
drugs are used as stated on the product label or throughout the year due to the chronic nature of the204
disease; 365 days a year and dosages as stated on the product label.205
206
EDtot (Length of exposure) was set to 65 years as the average for Ghanaian males and females based207
on the average life expectancy in Ghana, adult dose as stated on the product labels starts from age 12208
years (i.e. ED is 65-12 = 53 years) for HPA - HPE and from age 6 years (i.e. ED is 65-6 = 59 years)209
for HPF. IFR: Dosages as indicated on the product bottles (kg/person/day). C is the concentration of210
the contaminant metal/pesticide in the HMP (mg/kg). RfDo is the oral reference dose (mg /kg/day);211
BWa is the adult body weight (65 kg); ATn is the average exposure time for non-carcinogens can212
also be estimated as:213
ATn = EFr x EDtot ……………………………………………………………………………………. (4)214
215
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If the value of THQ is less than 1, then the exposed local population (consumers) is said to be safe.216
But if THQ is equal to or higher than 1, is considered as not safe for human health, therefore poses217
potential health risk, and related interventions and protective measurements should be taken.218
219
2.5.3 Hazard Index (HI)220
To estimate the risk to human health through more than one contaminant in a given product, the HI221
has been developed by US EPA, 1989, [36-37]. The chronic hazard index (HI) is the sum of more222
than one hazard quotient for multiple toxicants in the HP. It is believed that, exposure to two or more223
pollutants may result in additive and/or interactive effects, [38]. Assuming the additive effects, THQs224
can be summed across constituents to generate a hazard index (HI) for an oral dosage pathway225
combination, [38].226
HI = ∑ THQn ……………………………………………………………………. (5)227
228
Where; THQn is the targeted hazard quotient for the nth term of contaminant, HI is the hazard index229
230
2.5.4 Cancer risk estimation231
CR = CSF ∗ EDI …...………………………………………………………………….. (6)232
233
Where, CSF is the oral carcinogenic slope factor of 0.0085 (mg/kg/day) −1 for Pb set by CalEPA234
(OEHHA) [39] and 1.5 (mg/kg/day)−1 for arsenic (As) set by US EPA [40]. EDI is the estimated235
daily intake of heavy metals. Acceptable risk levels for carcinogens range from 10-4 (risk of236
developing cancer over a human lifetime is 1 in 10,000) to 10-6 (risk of developing cancer over a237




Study participants provided a written informed consent to participate in the study. Ethical clearance241
for the study was issued by the University of Cape Coast Institutional Review Board (UCCIRB)242
(ethical approval number: UCCIRB/EXT/2017/07).243
244
3.0 Results and discussion245
The internationally established legally permitted maximum residual limits (MRLs) were obtained246
from the literature, [22, 32, 41-42]. The toxicant level above the established MRLs poses a health risk247
to consumers and vice versa. It must be stated that chromium IV and VI have different toxicities and248
MRL for chromium (VI) was used for this study due to its higher toxicity compared to chromium249
(IV). In this study, all the measured chromium was assumed to be chromium VI with a similar reason250
as above. In this study, the maximum residual content of Cr, Mn, Ni, Cu and As were above the MRL251
in all the six herbal preparations (Table 1). This indicates that these metal contents are above the legal252
limits to be on the market. Pb contents for HPC, HPE and HPF were also below the MRL. It must be253
stated, however, that the MRLs are state or country dependent and vary from one state to the other.254
MRLs are essential for legal purposes but not conclusive for health risk estimation due to differing255
consumption frequencies, dosage variations and body weight differences.256
257
Health risk estimation based on the estimated daily intake (EDI) of the heavy metal contaminant is258
one of the vital health risk assessment tools. It takes into account the frequency and duration of259
exposure and the body weight of the exposed persons. The EDI for Cr, Mn, Ni, Cu, As, Cd, Pb, and260
Hg were all within the upper tolerable daily intake reference limits for HPA-HPE (Table 2). This261
indicates that the daily intake of these herbal products poses no short to mid-term heavy metal health262
risk to the public. The EDI for As was determined to be higher (2.48*10-04 mg/kg/day) than the upper263
tolerable daily intake reference limit (1.67*10-04 mg/kg/day) for HPF. This indicates that consumers264
of HPF are exposed to short-term to long-term arsenic health risk. Based on previous knowledge,265
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overexposure to arsenic is associated with risk of skin lesions, high blood pressure and diabetes266
mellitus [43]. There is also an increased risk of cancer [44].267
268
The herbal products do not pose long-term health risk per the metal considered if the Hazard risk269
index (HRI) value is less than 1; and poses a health risk if the HRI is equal to or greater than 1.270
HRI for non-carcinogenic effects measures the long-term exposure of the heavy metal contaminants271
present in the herbal preparations. The HRI for Cr, Mn, Ni, As, Cd, Pb, and Hg, were all less than 1272
(Table 3). This means that the consumption of these (HPA - HPF) poses no health risk due to these273
metals. However, the HRI of Cu for HPF (1.68) is greater than 1. This indicates that long-term274
exposure to HPF poses a health risk due to overexposure to copper. Copper is a microelement, but275
overexposure to this essential mineral has been reported to predispose the consumer276
to gastrointestinal mucosal ulcerations and bleeding, hepatic necrosis, coma, cardiotoxicity,277
hypotension [45], leukaemia and cancer [46]. Cd and Hg contents, on the other hand, were well below278
the MRL limits for all the 6 HPs.279
280
It is known that an HI value less than 1 implies that the exposed population is unlikely to experience281
any adverse health effect in their lifetime. However, if the THQ (Tables 4 and 5) is equal to or higher282
than 1, [25, 47-48], there is a potential health risk to the exposed population and related interventions283
and protective measures needed to be taken to protect the population. The HI values for HPA – HPE284
were less than 1. This indicates the combined effects of the heavy metal contaminants present in a285
particular herbal preparation poses no health risk in the long term for both adults (Fig. 2) and children286
(Fig. 3). The HI for HPF was higher than 1 probably due to a high daily intake of Cu in this HP. This287




The total cancer risk was within the acceptable limits for all the studied herbal products (fig. 3).291
Acceptable risk levels for carcinogens range from 10−4 (risk of developing cancer over a human292
lifetime is 1 in 10000) to 10−6 (risk of developing cancer over a human lifetime is 1 in 1000000),293
[35]. Values of CR lower than 10−6 are considered as negligible, above 10−4 are considered to be294
unacceptable and lying in between 10−6 and 10−4 are considered an acceptable range, [35]. The cancer295
risk estimation for As and Pb present in the six herbal products ranged between the values of 1.54*10-296
09 (least) to 3.73*10-04 (highest) and were all within the acceptable limits. The total cancer risk due to297
the sum total of risk presented by the individual carcinogenic metals presents per herbal preparation298
was also all within the acceptable limit. This observation indicates that the consumption of these299
herbal products does not pose any long-term cancer risk to the public.300
301
4.0 Conclusion302
The polyherbal products (HPA – HPF) evaluated in this study exhibited carcinogenic risk within303
acceptable limits. The non-carcinogenic health risk assessment suggests that five of the products304
(HPA to HPE) may be safe. However, this safety can be ascertained only when the health risks of305
these products are further characterized in detailed chronic toxicity studies. The high HI recorded for306
HPF, on the other hand, suggests increased health risks for consumers of this product. We advise,307
therefore, that the use of these polyherbal products, especially HPF, should be done with much308
caution. We also recommend that all relevant national and international agencies should be alive to309
the responsibility of promoting public safety and global health by periodically reviewing and310





The manufacturers of the herbal products including HPF have been briefed with the findings from315
this study. Recommendations were also made to the manufacturers to take steps in preventing metal316
contamination and ensure good manufacturing practices.317
318
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Table 1: Maximum heavy metal content (mg/kg) of the herbal medicinal products471
Sample Cr Mn Ni Cu As Cd Pb Hg
HPA 1.34427 3.34838 0.89544 8.32478 1.28474 0.0083 0.11961 ND
HPB 1.35674 3.33046 0.94961 8.13625 1.02657 0.00832 0.13969 0.00005
HPC 1.23508 3.92038 1.21877 8.78602 1.14446 0.00866 0.08068 ND
HPD 1.24268 2.28998 0.93383 8.57095 1.01004 0.00834 0.11712 0.002739
HPE 0.29191 0.84375 0.17287 1.75486 0.25989 0.00181 0.02338 ND
HPF 1.67602 2.82811 1.20886 9.171 1.35453 0.0083 0.0733 ND
MRLs 0.05 0.26      0.6 0.1 0.02 0.06 0.1 0.01




Table 2: Estimated daily intakes (EDI) of the heavy metals475
Sample Cr Mn Ni Cu As Cd Pb Hg
HPA 4.77*10-05 1.19*10-04 3.18*10-05 2.96*10-04 4.56*10-05 2.95*10-07 4.25*10-06 0
HPB 8.35*10-06 2.05*10-05 5.84*10-06 5.01*10-05 6.32*10-06 5.12*10-08 8.60*10-07 3.08*10-10
HPC 1.47*10-05 4.67*10-05 1.45*10-05 1.05*10-04 1.36*10-05 1.03*10-07 9.61*10-07 0
HPD 8.99*10-06 1.66*10-05 6.75*10-06 6.20*10-05 7.30*10-06 6.03*10-08 8.47*10-07 1.98*10-08
HPE 2.26*10-06 6.54*10-06 1.34*10-06 1.36*10-05 2.02*10-06 1.40*10-08 1.81*10-07 0
HPF 3.07*10-04 5.19*10-04 2.22*10-04 1.68*10-03 2.48*10-04 1.52*10-06 1.34*10-05 0
Upper tolerable daily intake Reference limits
CA HP
(mg/kg/day)
3.33*10-04 NA NA NA 1.67*10-04 1.00*10-04 3.33*10-04 3.33*10-04
WA
(mg/kg/day)
8.33*10-04 4.33*10-03 2.33*10-02 5.00*10-02 3.33*10-04 1.00*10-03 1.67*10-03 1.67*10-04
CA is for Canadian upper tolerable daily intake reference limits for finish herbal products (HP) in mg/kg476
(bw/day),1 and ‘WA’ is for WHO/FAO (mg/kg bw/day)42.477
HPA-F: herbal product A-F. NA means the upper tolerable daily intake reference limit for that particular478





Table 3: Hazard risk index (HRI) for HRI for non-carcinogenic effects483
Sample  Cr Mn Ni Cu As Cd Pb Hg
HPA 2.39*10-03 8.49*10-04 1.59*10-03 2.96*10-01 1.52*10-02 2.95*10-04 1.06*10-03 0
HPB 4.17*10-04 1.46*10-04 2.92*10-04 5.01*10-02 2.11*10-03 5.12*10-05 2.15*10-04 3.08*10-06
HPC 7.35*10-04 3.33*10-04 7.26*10-04 1.05*10-01 4.54*10-03 1.03*10-04 2.40*10-04 0
HPD 4.49*10-04 1.18*10-04 3.38*10-04 6.20*10-02 2.43*10-03 6.03*10-05 2.12*10-04 1.98*10-04
HPE 1.130*10-04 4.670*10-05 6.70*10-05 1.36*10-02 6.72*10-04 1.40*10-05 4.53*10-05 0
HPF 1.54*10-02 3.71*10-03 1.11*10-02 1.682 8.28*10-02 1.52*10-03 3.36*10-03 0





Table 4: THQ for adults using a body mass of 65 kg488
Sample Cr Mn Ni Cu As Cd Pb Hg
HPA 2.39*10-03 8.49*10-04 1.59*10-03 2.96*10-01 1.52*10-02 2.95*10-04 1.06*10-03 0
HPB 4.00*10-05 1.40*10-05 2.80*10-05 4.80*10-03 2.02*10-04 4.91*10-06 2.06*10-05 2.95*10-07
HPC 2.12*10-04 9.61*10-05 2.09*10-04 3.02*10-02 1.31*10-03 2.97*10-05 6.92*10-05 0
HPD 2.46*10-04 6.48*10-05 1.85*10-04 3.41*10-02 1.33*10-03 3.30*10-05 1.16*10-04 1.09*10-04
HPE 1.13*10-04 4.67*10-05 6.70*10-05 1.36*10-02 6.72*10-04 1.40*10-05 4.53*10-05 0
HPF 1.54*10-02 3.71*10-03 1.11*10-02 1.68 8.28*10-02 1.52*10-03 3.36*10-03 0
HPA-F: herbal product A-F; THQ: targeted hazard quotient. The bolded value represents THQ489





Table 5: THQ for kids using a body mass of 24 kg494
Sample Cr Mn Ni Cu As Cd Pb Hg
HPA 6.46*10-03 2.30*10-03 4.306*10-03 8.01*10-01 4.12*10-02 7.98*10-04 2.88*10-03 0
HPB 5.42*10-05 1.90*10-05 3.79*10-05 6.50*10-03 2.73*10-04 6.65*10-06 2.79*10-05 4.00*10-07
HPC 5.73*10-04 2.60*10-04 5.65*10-04 8.15*10-02 3.54*10-03 8.03*10-05 1.87*10-04 0
HPD 3.33*10-04 8.78*10-05 2.51*10-04 4.60*10-02 1.81*10-03 4.47*10-05 1.57*10-04 1.47*10-04
HPE NA NA NA NA NA NA NA NA
HPF 4.16*10-02 1.00*10-02 3.00*10-02 4.56 2.24*10-01 4.12*10-03 9.10*10-03 0
HPA-F: herbal product A-F; THQ: targeted hazard quotient; NA: not applicable, for the product495






Figure 1: Chronic Hazard Index (HI) for adults.501







Figure 2: Chronic Hazard Index (HI) for Kids.508







Figure 3: Estimated cancer risk (CR) for the herbal medicinal products HPA-F515
516
The cancer risk (CR) values for herbal products A-F are all within the acceptable limit. The total517
cancer risk (TCR) as a result of the sum total of the individual cancer risk present by the carcinogenic518
metals per herbal preparation were also within the acceptable limit. It was observed that, the519
contribution of carcinogenic risk from As was much higher than contribution of CR from Pb in all520
the herbal products.521
522
CR is for cancer risk. Total CR is for total cancer risk per herbal preparation which is the sum total523









Figure 4A: Commonly patronized antimalarial herbal medicinal preparations among surveyed532
participants in the Kumasi metropolis of Ghana. The bars with the star represent the top-three most533



















Figure 4B: Commonly patronized antidiabetic herbal medicinal preparations among surveyed participants in539
the Kumasi metropolis of Ghana. The bars with the star represent the top-two most patronized antidiabetic540





























Figure 4C: Commonly patronized antihypertensive herbal medicinal preparations among surveyed546
participants in the Kumasi metropolis of Ghana. The number of respondents for antihypertensive547
herbal preparations was 11. The bar with the star represents the top-one most patronized548
antihypertensive herbal medicinal product selected for the study. The second most patronized549
product ‘Osompa’ diabetes and pressure’ is used for the treatment of both diabetes and pressure and550
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